These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2043219)

  • 1. Effects of antihypertensive therapy on glucose tolerance: focus on calcium antagonists.
    Hedner T; Samuelsson O; Lindholm L
    J Intern Med Suppl; 1991; 735():101-11. PubMed ID: 2043219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of diuretics, calcium antagonists, and alpha-blockers on insulin sensitivity and glucose tolerance in hypertensive patients.
    Ramsay LE; Yeo WW; Jackson PR
    J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S49-53; discussion S53-4. PubMed ID: 1284144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nifedipine, captopril and prazosin on secretory function of pancreatic beta-cells in hypertensive patients with type-2 (non-insulin-dependent) diabetes and in hypertensive non-diabetics.
    Jasik M; Kasperska-Dworak A; Czyzyk A
    Diabetes Res Clin Pract; 1996 Jun; 33(1):59-66. PubMed ID: 8877277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel antagonists and the treatment of migraine.
    Greenberg DA
    Clin Neuropharmacol; 1986; 9(4):311-28. PubMed ID: 2425960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium entry blockers and their effects on glucose metabolism.
    Kingma PJ; Simons JP; Nieuwenhuijzen Kruseman AC; Wolffenbuttel BH
    Neth J Med; 1990 Feb; 36(1-2):32-8. PubMed ID: 2179750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nitrendipine and other calcium antagonists on glucose metabolism in man.
    Trost BN; Weidmann P
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S986-95. PubMed ID: 6085390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of calcium channel antagonists in modifying the inhibitory influence of adenosine on insulin secretion.
    Ismail NA; Shaheen AA; el-Sawalhi MM; Megahed YM
    Arzneimittelforschung; 1995 Aug; 45(8):865-8. PubMed ID: 7575748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism and calcium antagonists.
    Trost BN
    Horm Metab Res Suppl; 1990; 22():48-56. PubMed ID: 2202627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil, a phenylalkylamine Ca2+ channel blocker, inhibits ATP-sensitive K+ channels in insulin-secreting cells from rats.
    Lebrun P; Antoine MH; Ouedraogo R; Pirotte B; Herchuelz A; Cosgrove KE; Kane C; Dunne MJ
    Diabetologia; 1997 Dec; 40(12):1403-10. PubMed ID: 9447947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological basis for use of calcium antagonists in hypertension.
    Scriabine A; Kazda S
    Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part I).
    O'Byrne S; Feely J
    Drugs; 1990 Jul; 40(1):6-18. PubMed ID: 2202583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemic and calcium-antagonistic effects on insulin release and oral glucose tolerance in man.
    Andersson DE; Röjdmark S; Hed R; Sundblad L
    Acta Med Scand; 1982; 211(1-2):35-43. PubMed ID: 7041521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists and blood glucose in normal rabbits.
    Patel RB; Shah GF; Raval JD; Gandhi TP; Gilbert RN
    Arzneimittelforschung; 1987 Apr; 37(4):410-2. PubMed ID: 3300662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of voltage-gated Ca2+ channels and insulin secretion in HIT cells by the Ca2+/calmodulin-dependent protein kinase II inhibitor KN-62: comparison with antagonists of calmodulin and L-type Ca2+ channels.
    Li G; Hidaka H; Wollheim CB
    Mol Pharmacol; 1992 Sep; 42(3):489-8. PubMed ID: 1328847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thapsigargin-sensitive cationic current leads to membrane depolarization, calcium entry, and insulin secretion in rat pancreatic beta-cells.
    Cruz-Cruz R; Salgado A; Sánchez-Soto C; Vaca L; Hiriart M
    Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E439-45. PubMed ID: 15811875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of verapamil, diltiazem, nifedipine and propranolol on metabolic control in hypertensives with non-insulin dependent diabetes mellitus.
    Chellingsworth MC; Kendall MJ; Wright AD; Singh BM; Pasi J
    J Hum Hypertens; 1989 Feb; 3(1):35-9. PubMed ID: 2657057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of high-voltage-activated calcium channels in glucose-regulated beta-cell calcium homeostasis and insulin release.
    Taylor JT; Huang L; Keyser BM; Zhuang H; Clarkson CW; Li M
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E900-8. PubMed ID: 15956052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse effects of calcium channel blockers on skeletal muscle glucose transport.
    Cartee GD; Briggs-Tung C; Holloszy JO
    Am J Physiol; 1992 Jul; 263(1 Pt 2):R70-5. PubMed ID: 1636796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cellular calcium metabolism in abnormal glucose metabolism and diabetic hypertension.
    Levy J; Zemel MB; Sowers JR
    Am J Med; 1989 Dec; 87(6A):7S-16S. PubMed ID: 2688414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.